CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells

Journal of Translational Medicine

Volumn 9, Issue , 2011, Pages

  Rubie, Claudia ^a   Frick, Vilma O ^a   Ghadjar, Pirus ^b   Wagner, Mathias ^a   Justinger, Christoph ^a   Faust, Sabrina K ^a   Vicinus, Benjamin ^a   Gräber, Stefan ^a   Kollmar, Otto ^a   Schilling, Martin K ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MESSENGER RNA; NEUTRALIZING ANTIBODY; SMALL INTERFERING RNA; BLOCKING ANTIBODY; CXCL12 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; STROMAL CELL DERIVED FACTOR 1;

ADULT; AGED; ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN CACO 2; CELL STRAIN HT29; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MIGRATION INHIBITION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; ANTIBODY SPECIFICITY; CELL MOTION; COLORECTAL TUMOR; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE;

AGED; ANTIBODIES, BLOCKING; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; MALE; MIDDLE AGED; ORGAN SPECIFICITY; RECEPTORS, CXCR4; RNA, MESSENGER;

EID: 79951944666     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-22     Document Type: Article

References (42)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics 2005. CA Cancer J Clin 2005, 55:10-30. 10.3322/canjclin.55.1.10, 15661684.
2. Zlotnik A. Involvement of chemokine receptors in organ-specific metastasis. Contrib Microbiol 2006, 13:191-199. full_text, 16627966.
3. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
4. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strieter RM. The stromal derived factor -1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung metastases. Am J Respir Crit Care Med 2003, 167:1667-1686.
5. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-638. 10.1038/382635a0, 8757135.
6. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Sprinter TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996, 184:1101-1109. 10.1084/jem.184.3.1101, 2192798, 9064327.
7. Kim CH, Pelus LM, White JR, Broxmeyer HE. Differential chemotactic behavior of developing T cells in response to thymic chemokines. Blood 1998, 91:4434-4443.
8. Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 2004, 35:233-245. 10.1023/B:HIJO.0000032355.66152.b8, 15339043.
9. Iwasa S, Yanagawa T, Fan J, Katoh R. Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis. Anticancer Res 2009, 29:4751-4758.
10. Wang L, Wang L, Yang B, Yang Q, Qiao S, Wang Y, Sun Y. Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis. Clin Exp Metastasis 2009, 26:1049-1054. 10.1007/s10585-009-9294-3, 19859817.
11. Robledo MM, Bartolome RA, Longo N, Rodríguez-Frade JM, Mellado M, Longo I, van Muijen GN, Sánchez-Mateos P, Teixidó J. Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem 2001, 276:45098-45105. 10.1074/jbc.M106912200, 11571298.
12. Carlisle AJ, Lyttle CA, Carlisle RY, Maris JM. CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation. Mol Cancer 2009, 8:126-139. 10.1186/1476-4598-8-126, 2807429, 20028517.
13. Burger JA, Burger M, Kipps TJ. Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 1999, 94:3658-3667.
14. Singh S, Malik BK, Sharma DK. Targeting HIV-1 through molecular modeling and docking studies of CXCR4: leads for therapeutic development. Chem Biol Drug Des 2007, 69:191-203. 10.1111/j.1747-0285.2007.00478.x, 17441905.
15. Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, Foshag L, Bilchik AJ, Hoon DS. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 2005, 23:2744-2753. 10.1200/JCO.2005.07.078, 15837989.
16. Rubie C, Kollmar O, Frick VO, Wagner M, Brittner B, Gräber S, Schilling MK. Differential CXC receptor expression in colorectal carcinomas. Scand J Immunol 2008, 68:635-644.
17. Rubie C, Oliveira Frick V, Wagner M, Weber C, Kruse B, Kempf K, König J, Rau B, Schilling M. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases. World J Gastroenterol 2006, 41:6627-6633.
18. Zeelenberg IS, Ruuls-Van Stalle L, Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 2003, 63:3833-3839.
19. Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, Nasti G, Barletta E, Facchini G, Daniele B, Di Blasi A, Napoletano M, Ieranó C, Calemma R, Leopardi E, Albino V, De Angelis V, Falanga M, Boccia V, Capuozzo M, Parisi V, Botti G, Castello G, Vincenzo Iaffaioli R, Scala S. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Clin Cancer Res 2006, 12:2795-2803. 10.1158/1078-0432.CCR-05-2142, 16675573.
20. Ingold B, Schulz S, Budczies J, Neumann U, Ebert MP, Weichert W, Röcken C. The role of vascular CXCR4 expression in colorectal carcinoma. Histopathology 2009, 55:576-586. 10.1111/j.1365-2559.2009.03426.x, 19912363.
21. Wittekind CH, Meyer HJ, Bootz F. UICC TNM classification of malignant tumors. 2002, Springer, Berlin, Heidelberg, New York, 6.
22. Ishizu K, Sunose N, Yamazaki K, Tsuruo T, Sadahiro S, Makuuchi H, Yamori T. Development and characterization of a model of liver metastasis using human colon cancer HCT-116 cells. Biol Pharm Bull 2007, 30:1779-1783. 10.1248/bpb.30.1779, 17827739.
23. Kyriazis AP, DiPersio L, Michael GJ, Pesce AJ, Stinnett JD. Growth patterns and metastatic behavior of human tumors growing in athymic mice. Cancer Res 1978, 38:3186-3190.
24. Hamada K, Monnai M, Kawai K, Nishime C, Kito C, Miyazaki N, Ohnishi Y, Nakamura M, Suemizu H. Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice. Int J Oncol 2008, 32:153-159.
25. Bustin SA. Absolute quantification of mRNA using real time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2002, 25:169-193.
26. Rubie C, Kempf K, Hans J, Su T, Tilton B, Georg T, Brittner B, Ludwig B, Schilling M. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. Mol Cell Probe 2005, 19:101-109.
27. Rubie C, Oliveira V, Kempf K, Wagner M, Tilton B, Rau B, Kruse B, König J, Schilling M. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumor Biol 2006, 27:166-174.
28. Saigusa S, Toiyama Y, Tanaka K, Yokoe T, Okugawa Y, Kawamoto A, Yasuda H, Inoue Y, Miki C, Kusunoki M. Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy. Ann Surg Oncol 2010, 17:2051-2058. 10.1245/s10434-010-0970-y, 20177796.
29. Brand S, Dambacher J, Beigel F, Olszak T, Diebold J, Otte JM, Göke B, Eichhorst ST. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 2005, 310:117-130. 10.1016/j.yexcr.2005.07.006, 16125170.
30. Oliveira Frick V, Rubie C, Ghadjar P, Faust SK, Wagner M, Gräber S, Schilling MK. Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies. Tumour Biol 2011, 32:189-196. 10.1007/s13277-010-0112-y, 20865359.
31. Wendt MK, Johanesen PA, Kang-Decker N, Binion DG, Shah V, Dwinell MB. Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene 2006, 25:4986-4997. 10.1038/sj.onc.1209505, 16568088.
32. Wendt MK, Drury LJ, Vongsa RA, Dwinell MB. Constitutive CXCL12 expression induces anoikis in colorectal carcinoma cells. Gastroenterology 2008, 135:508-517. 10.1053/j.gastro.2008.05.033, 2583344, 18558091.
33. Drury LJ, Wendt MK, Dwinell MB. CXCL12 chemokine expression and secretion regulates colorectal carcinoma cell anoikis through bim-mediated intrinsic apoptosis. PLoS One 2010, 5:e12895. 10.1371/journal.pone.0012895, 2943927, 20877573.
34. Wendt MK, Cooper AN, Dwinell MB. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells. Oncogene 2008, 27:1461-1471. 10.1038/sj.onc.1210751, 17724466.
35. Dessein AF, Stechly L, Jonckheere N, Dumont P, Monté D, Leteurtre E, Truant S, Pruvot FR, Figeac M, Hebbar M, Lecellier CH, Lesuffleur T, Dessein R, Grard G, Dejonghe MJ, de Launoit Y, Furuichi Y, Prévost G, Porchet N, Gespach C, Huet G. Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells. Cancer Res 2010, 70:4644-4654. 10.1158/0008-5472.CAN-09-3828, 20460542.
36. Schimanski CC, Schwald S, Simiantonaki N, Jayasinghe C, Gönner U, Wilsberg V, Junginger T, Berger MR, Galle PR, Moehler M. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res 2005, 11:1743-1750. 10.1158/1078-0432.CCR-04-1195, 15755995.
37. Ottaiano A, di Palma A, Napolitano M, Pisano C, Pignata S, Tatangelo F, Botti G, Acquaviva AM, Castello G, Ascierto PA, Iaffaioli RV, Scala S. Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells. Cancer Immunol Immunother 2005, 54:781-791. 10.1007/s00262-004-0636-3, 15592929.
38. Kim J, Mori T, Chen SL, Amersi FF, Martinez SR, Kuo C, Turner RR, Ye X, Bilchik AJ, Morton DL, Hoon DS. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg 2006, 244:113-120. 10.1097/01.sla.0000217690.65909.9c, 1570598, 16794396.
39. Kollmar O, Rupertus K, Scheuer C, Junker B, Tilton B, Schilling MK, Menger MD. Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. Neoplasia 2007, 9:862-870. 10.1593/neo.07559, 2040213, 17971906.
40. Shen X, Artinyan A, Jackson D, Thomas RM, Lowy AM, Kim J. Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways. Pancreas 2010, 39:81-87. 10.1097/MPA.0b013e3181bb2ab7, 19820417.
41. Hong JS, Pai HK, Hong KO, Kim MA, Kim JH, Lee JI, Hong SP, Hong SD. CXCR-4 knockdown by small interfering RNA inhibits cell proliferation and invasion of oral squamous cell carcinoma cells. J Oral Pathol Med 2009, 38:214-219. 10.1111/j.1600-0714.2008.00671.x, 18624931.
42. Gassmann P, Haier J, Schlüter K, Domikowsky B, Wendel C, Wiesner U, Kubitza R, Engers R, Schneider SW, Homey B, Müller A. CXCR4 regulates the early extravasation of metastatic tumor cells in vivo. Neoplasia 2009, 11:651-661. 2697351, 19568410.